PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-134.19%
Both yoy net incomes decline, with CNQ at -22.98%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.75%
Less D&A growth vs. CNQ's 122.52%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-82.16%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
81.45%
Less working capital growth vs. CNQ's 320.25%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
83.34%
Growth of 83.34% while CNQ is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-1545.00%
Negative yoy while CNQ is 181.25%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
215.67%
Operating cash flow growth above 1.5x CNQ's 32.18%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-16.70%
Both yoy lines negative, with CNQ at -51.11%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
42.47%
Acquisition growth of 42.47% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
23.58%
Purchases growth of 23.58% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
16.70%
Liquidation growth of 16.70% while CNQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-11.67%
Both yoy lines negative, with CNQ at -220.61%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-3.17%
Both yoy lines negative, with CNQ at -143.45%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment 1.25-1.5x CNQ's 83.90%. Bruce Berkowitz would see an edge in lowering interest burdens unless competitor invests in profitable expansions.
-75.00%
Both yoy lines negative, with CNQ at -15.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
44.06%
Buyback growth of 44.06% while CNQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.